BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14621192)

  • 1. Function of HSP90 and p23 in the telomerase complex of thyroid tumors.
    Boltze C; Schneider-Stock R; Roessner A; Quednow C; Hoang-Vu C
    Pathol Res Pract; 2003; 199(9):573-9. PubMed ID: 14621192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of telomerase genes in thyroid carcinoma.
    Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
    Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma.
    Boltze C; Lehnert H; Schneider-Stock R; Peters B; Hoang-Vu C; Roessner A
    Endocrine; 2003 Dec; 22(3):193-201. PubMed ID: 14709792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of telomerase activity by six telomerase subunits.
    Chang JT; Chen YL; Yang HT; Chen CY; Cheng AJ
    Eur J Biochem; 2002 Jul; 269(14):3442-50. PubMed ID: 12135483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profile of the telomeric complex discriminates between benign and malignant pheochromocytoma.
    Boltze C; Mundschenk J; Unger N; Schneider-Stock R; Peters B; Mawrin C; Hoang-Vu C; Roessner A; Lehnert H
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4280-6. PubMed ID: 12970299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.
    Liou MJ; Chan EC; Lin JD; Liu FH; Chao TC
    Cancer Lett; 2003 Mar; 191(2):223-7. PubMed ID: 12618337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human telomerase reverse transcriptase expression in Diff-Quik-stained FNA samples from thyroid nodules.
    Siddiqui MT; Greene KL; Clark DP; Xydas S; Udelsman R; Smallridge RC; Zeiger MA; Saji M
    Diagn Mol Pathol; 2001 Jun; 10(2):123-9. PubMed ID: 11385322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of human telomerase reverse transcriptase gene expression in thyroid follicular tumors by fine-needle aspirations using in situ hybridization.
    Kammori M; Nakamura K; Hashimoto M; Ogawa T; Kaminishi M; Takubo K
    Int J Oncol; 2003 May; 22(5):985-91. PubMed ID: 12684663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of telomerase genes correlates with telomerase activity in human colorectal carcinogenesis.
    Yan P; Saraga EP; Bouzourene H; Bosman FT; Benhattar J
    J Pathol; 2001 Jan; 193(1):21-6. PubMed ID: 11169511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity in human thyroid carcinomas originating from the follicular cells.
    Brousset P; Chaouche N; Leprat F; Branet-Brousset F; Trouette H; Zenou RC; Merlio JP; Delsol G
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4214-6. PubMed ID: 9398742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.
    Zeiger MA; Smallridge RC; Clark DP; Liang CK; Carty SE; Watson CG; Udelsman R; Saji M
    Surgery; 1999 Dec; 126(6):1195-8; discussion 1198-9. PubMed ID: 10598207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues.
    Kyo S; Kanaya T; Takakura M; Tanaka M; Inoue M
    Int J Cancer; 1999 Jan; 80(1):60-3. PubMed ID: 9935231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.
    Boltze C; Schneider-Stock R; Quednow C; Hinze R; Mawrin C; Hribaschek A; Roessner A; Hoang-Vu C
    Int J Mol Med; 2003 Oct; 12(4):479-84. PubMed ID: 12964023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human telomerase reverse transcriptase (hTERT) gene expression in thyroid carcinoma: diagnostic and prognostic role.
    Asaad NY; Abd El-Wahed MM; Mohammed AG
    J Egypt Natl Canc Inst; 2006 Mar; 18(1):8-16. PubMed ID: 17237847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
    Wang N; Liu T; Sofiadis A; Juhlin CC; Zedenius J; Höög A; Larsson C; Xu D
    Cancer; 2014 Oct; 120(19):2965-79. PubMed ID: 24898513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus.
    Yu HP; Xu SQ; Lu WH; Li YY; Li F; Wang XL; Su YH
    J Surg Oncol; 2004 May; 86(2):99-104. PubMed ID: 15112252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms.
    Saji M; Xydas S; Westra WH; Liang CK; Clark DP; Udelsman R; Umbricht CB; Sukumar S; Zeiger MA
    Clin Cancer Res; 1999 Jun; 5(6):1483-9. PubMed ID: 10389936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable association of hsp90 and p23, but Not hsp70, with active human telomerase.
    Forsythe HL; Jarvis JL; Turner JW; Elmore LW; Holt SE
    J Biol Chem; 2001 May; 276(19):15571-4. PubMed ID: 11274138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo.
    Cabuy E; de Ridder L
    Virchows Arch; 2001 Aug; 439(2):176-84. PubMed ID: 11561758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase activity in benign and malignant thyroid tumors.
    Haugen BR; Nawaz S; Markham N; Hashizumi T; Shroyer AL; Werness B; Shroyer KR
    Thyroid; 1997 Jun; 7(3):337-42. PubMed ID: 9226200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.